Rheumatoid Arthritis Clinical Trials in Chicago

Showing 981-1000 of 3,348 trials

9-ING-41 in Pediatric Patients With Refractory Malignancies.

NCT04239092

9-ING-41 has anti-cancer clinical activity with no significant toxicity in adult patients. This Phase 1 study will study its efficacy in paediatric patients with advanced malignancies.

Refractory CancerRefractory NeoplasmCancer Pediatric+8 more

Actuate Therapeutics Inc.40 participantsStarted Jun 2020

San Francisco, California, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +6 more locations

COMPLETEDPhase 22.2 miles

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

NCT03603808

This phase II trial studies the use of human papillomavirus (HPV) deoxyribonucleic acid (DNA) plasmids therapeutic vaccine VGX-3100 (VGX-3100) and electroporation in treating patients with human immunodeficiency virus (HIV)-positive high-grade anal lesions. Vaccines made from DNA may help the body build an effective immune response to kill tumor cells. Electroporation helps pores in your body's cells take in the drug to strengthen your immune system's response. Giving VGX-3100 and electroporation together may work better in treating patients with high-grade anal lesions.

Anal Intraepithelial NeoplasiaHigh Grade Squamous Intraepithelial NeoplasiaHIV Positivity+2 more

AIDS Malignancy Consortium35 participantsStarted Sep 2018

San Francisco, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

9-ING-41 in Pediatric Patients With Refractory Malignancies.

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Rheumatoid Arthritis Trials in Other Cities

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

CCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)

MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Neuromodulation and Yoga for Mild Traumatic Brain Injury and Chronic Pain

Expanded Clinical Study of the Tendyne Mitral Valve System

MitraClip EXPAND G4 Study

A Study to Compare Nighttime Aligners to Daytime Aligners

RNS System NAUTILUS Study

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)

Long Term Follow Up for CTSN Mitral Valve Repair Studies

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

The Life STORRIED Study

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Other Conditions in Chicago